Biotech firm FDNA has partnered with research organisations to create Greenwood Genetic Center , which will use Greenwood Genetic Center 's artificial intelligence and machine learning technologies. Two patient advocacy groups—Bridge the Gap representing patients with Fragile X, Angelman and other related syndromes as well as Kabuki syndrome group Steve Skinner , director at M.D. FDNA (GGC), which is part of the collaboration, said FDNA 's Face2Gene technology is central to the project, with the GGC team using the app and other tools to identify genetic syndromes. Researchers at Lausanne will investigate the relationship between bone structure and genomic data in patients with skeletal dysplasia disorders. Variantyx projects will perform facial analyses to improve early diagnosis and treatments.
Biotech firm FDNA has partnered with research organisations to create Greenwood Genetic Center , which will use Greenwood Genetic Center 's artificial intelligence and machine learning technologies. Steve Skinner , director at M.D. FDNA (GGC), which is part of the collaboration, said FDNA 's Face2Gene technology is central to the project, with the GGC team using the app and other tools to identify genetic syndromes. Researchers at Lausanne will investigate the relationship between bone structure and genomic data in patients with skeletal dysplasia disorders. Variantyx projects will perform facial analyses to improve early diagnosis and treatments.